Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late

Facebook0TwitterLinkedinGilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Gilead Sciences and Bristol-Myers Squibb urged A california federal judge Thursday to nix direct purchasers’ claims alleging the pharmaceutical businesses involved with anti-competitive conduct to block generic competition and keep HIV medicine costs artificially high, arguing the matches must be provided for arbitration or dumped as time-barred. Bing Defeats ‘Loot … Read More